Back to Journals » OncoTargets and Therapy » Volume 6

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer

Total article views   HTML views PDF downloads Totals
17,329 Dovepress* 10,836+ 2,052 12,888
PubMed Central* 6,493 1,398 7,891
Totals 17,329 3,450 20,779
*Since 14 February 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 1 0 0 3 10

View citations on PubMed Central and Google Scholar